Berna Biotech to divest its veterinary business Gräub AG

10-Apr-2006

Berna Biotech announced that it has reached agreement on the sale of all its shares in the veterinary pharmaceuticals production company Dr. E. Gräub AG. The company will become a subsidiary of VETINVEST GmbH, a German company investing in the field of veterinary medicines.

Berna decided to sell the fully owned Dr. E. Gräub, which employs 40 people, as production and sales of veterinary medicines are not among its core activities. This divestment is an important step towards aligning Berna's portfolio of activities with its strategic priorities.

The transaction will be formally concluded immediately upon approval by the competent competition authorities. Financial details were not disclosed.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances